.png)
Important Note: This information is intended for patient education and support. It is not a substitute for individualized medical advice. Treatment decisions should always be made with your own medical team, ideally including specialists experienced in appendix cancer, pseudomyxoma peritonei (PMP), cytoreductive surgery, and HIPEC.
What is Signet Ring Cell Adenocarcinoma?
Signet ring cell adenocarcinoma is a rare and aggressive form of appendix cancer.
The cancer cells contain mucin that pushes the nucleus to one side, giving them a “signet ring” appearance under the microscope.
What This Means
This is considered a high-grade, fast-growing cancer.
It is more likely to:
-
Spread early
-
Involve the abdominal lining
-
Affect lymph nodes and other organs
Prompt and specialized treatment is important.
Symptoms
Symptoms may include:
-
Abdominal pain
-
Bloating or swelling
-
Changes in bowel habits
-
Weight loss
-
Fatigue
How It's Diagnosed
Diagnosis involves:
-
Surgical removal or biopsy
-
Pathology confirmation
-
Imaging (CT, PET scans)
-
Blood tests and tumor markers in some cases
Treatment Options
Treatment often includes:
-
Systemic chemotherapy
-
Cytoreductive surgery (CRS) in select cases
-
HIPEC when appropriate
-
Ongoing oncology care
Prognosis & Outlook
This is one of the more aggressive appendix cancers.
Outcomes vary, but treatment advances continue to improve options and care strategies.
This diagnosis can feel especially overwhelming.
Focus on the next step—not the whole journey. You deserve clear information, strong support, and compassionate care.
For a more in-depth look at PMP, download the PMP Patient Handbook
423-438-3799